Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia

Cognitive impairment is a core feature of schizophrenia as deficits are present in the majority of patients, frequently precede the onset of other positive symptoms, persist even with successful treatment of positive symptoms, and account for a significant portion of functional impairment in schizop...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gray, John A., Roth, Bryan L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2007
Konular:
Special Theme: Progress on NIMH Initiatives (Memorial Theme for Wayne Fenton, MD) William Carpenter, Steve Marder, and Ellen Stover
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2632344/
https://ncbi.nlm.nih.gov/pubmed/17617664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbm074
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller